Skip to main content
RecallsAboutBlog

Drug recalls

Drug recalls from FDA, newest first.
Filters · 1Sort Newest
Agency
Risk level
Date
Sold in

4 recalls

Encon Safety Products Aquarion Preserved Cartridges

The Aquarion Preserved Cartridges have cGMP deviations.

Moderate risk, FDA, Manufacturing problem

Sun Pharmaceutical Clindamycin Phosphate Topical Solution

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Low risk, FDA, Drug impurity

Alvogen Levothyroxine Sodium Tablets Thy-Tabs

Levothyroxine Sodium Tablets, USP, Thyro-Tabs may contain 88 mcg tablets instead of 150 mcg tablets.

Moderate risk, FDA, Labeling error

Gold Star Distribution Advil, Aleve, Tylenol and More Over-the-Counter Medicines

Gold Star Distribution medicines have CGMP deviations.

Moderate risk, FDA, Manufacturing problem

1 recall

Taro Pharmaceuticals Fluocinolone Acetonide Topical Solution

Fluocinolone Acetonide Solution Topical Solution failed impurity specifications due to an out-of-specification result for known impurity D.

Low risk, FDA, Drug impurity

1 recall

Herbs Forever Ayurvedic Herbal Supplements

HerbsForever Hingwastik Churna and Gastro Care dietary supplements may contain undeclared wheat, posing a risk of serious allergic reactions.

High risk, FDA, Undeclared wheat

3 recalls

123Herbals Silintan 25 Pills

Silintan capsules contain undeclared meloxicam, which can cause serious life-threatening events.

High risk, FDA, Hidden drug ingredient

SpecGx Oxycodone and Acetaminophen CII Tablets

Oxycodone and Acetaminophen CII Tablets may have a missing imprint on the tablets.

Moderate risk, FDA, Quality testing problem

AvKARE Rosuvastatin Tablets

Rosuvastatin Tablets, USP, 10 mg, are out of specification for dissolution.

Moderate risk, FDA, Drug dissolving problem

1 recall

MediNatura ReBoost and ClearLife Nasal Sprays

ReBoost Nasal Spray and ClearLife Allergy Nasal Spray contain yeast, mold, and microbial contamination.

High risk, FDA, Contamination

2 recalls

Alembic Fesoterodine Fumarate Extended-Release Tablets

Failed impurities/degradation specifications due to levels of 'Diester Impurity' exceeding the specification limit.

Low risk, FDA, Drug impurity

Imprimis NJOF Dexamethasone Moxifloxacin and Tri-Moxi+ Intraocular Injections

Dexamethasone Moxifloxacin intraocular injections contain particulate matter - glass like particles.

Moderate risk, FDA, Foreign object